Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 06 04:00PM ET
3.15
Dollar change
+0.18
Percentage change
6.06
%
Index- P/E- EPS (ttm)-2.00 Insider Own32.32% Shs Outstand42.51M Perf Week-3.96%
Market Cap142.03M Forward P/E- EPS next Y-2.97 Insider Trans0.00% Shs Float28.77M Perf Month-12.74%
Income-84.05M PEG- EPS next Q-0.83 Inst Own45.06% Short Float2.12% Perf Quarter10.92%
Sales66.52M P/S2.14 EPS this Y5.26% Inst Trans-5.85% Short Ratio4.99 Perf Half Y-18.81%
Book/sh4.12 P/B0.77 EPS next Y-40.71% ROA-34.11% Short Interest0.61M Perf Year-44.54%
Cash/sh3.98 P/C0.79 EPS next 5Y- ROE-41.17% 52W Range2.71 - 8.49 Perf YTD-56.85%
Dividend Est.- P/FCF- EPS past 5Y-41.74% ROI-47.94% 52W High-62.90% Beta0.70
Dividend TTM- Quick Ratio6.45 Sales past 5Y1420.60% Gross Margin97.03% 52W Low16.24% ATR (14)0.25
Dividend Ex-Date- Current Ratio6.45 EPS Y/Y TTM14.38% Oper. Margin-137.25% RSI (14)48.51 Volatility8.66% 8.17%
Employees179 Debt/Eq0.01 Sales Y/Y TTM18.19% Profit Margin-126.34% Recom1.29 Target Price12.50
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q-80.75% Payout- Rel Volume1.57 Prev Close2.97
Sales Surprise-100.00% EPS Surprise7.00% Sales Q/Q-100.00% EarningsNov 07 BMO Avg Volume122.34K Price3.15
SMA20-0.07% SMA50-5.82% SMA200-14.65% Trades Volume191,761 Change6.06%
Date Action Analyst Rating Change Price Target Change
Jun-09-23Upgrade Stifel Hold → Buy $11 → $16
Feb-03-23Downgrade Morgan Stanley Overweight → Equal-Weight $28 → $15
Jan-06-23Initiated CapitalOne Overweight $28
Apr-12-22Downgrade Stifel Buy → Hold $11
Mar-17-22Resumed Goldman Buy $43
Sep-23-21Initiated Stifel Buy $48
Sep-13-21Initiated H.C. Wainwright Buy $54
Jun-28-21Initiated Guggenheim Buy $46
Mar-01-21Initiated Berenberg Buy $51
Oct-28-20Initiated Northland Capital Outperform $38
Nov-12-24 07:05AM
Nov-07-24 07:05AM
Oct-24-24 05:57AM
Oct-23-24 06:05AM
Oct-14-24 10:39AM
07:05AM Loading…
07:05AM
Sep-30-24 04:05PM
Sep-23-24 07:05AM
Sep-13-24 07:00AM
Aug-29-24 09:33AM
05:19AM
Aug-28-24 04:05PM
Aug-27-24 07:05AM
Aug-06-24 05:50PM
04:05PM
09:00AM Loading…
Jul-16-24 09:00AM
Jun-26-24 10:30AM
Jun-10-24 07:05AM
Jun-06-24 09:59AM
Jun-05-24 06:28AM
Jun-04-24 04:05PM
Jun-03-24 04:05PM
May-29-24 07:05AM
May-08-24 07:39AM
07:31AM
May-07-24 10:55PM
04:05PM
Apr-30-24 07:05AM
07:05AM
Apr-26-24 04:05PM
07:05AM Loading…
Feb-29-24 07:05AM
Feb-28-24 07:36AM
07:05AM
Feb-20-24 10:00AM
Feb-15-24 07:05AM
Feb-13-24 04:45AM
Feb-12-24 04:05PM
Jan-25-24 07:00AM
Jan-08-24 07:00AM
Jan-04-24 04:05PM
Dec-29-23 04:05PM
Nov-20-23 08:19AM
Nov-15-23 07:00AM
Nov-09-23 11:38AM
08:16AM
07:00AM
Nov-07-23 07:00AM
Nov-06-23 11:35AM
07:00AM
Oct-13-23 09:40AM
Oct-11-23 09:35AM
Oct-09-23 09:35AM
Oct-03-23 07:00AM
Sep-20-23 04:26AM
Sep-19-23 07:00AM
Sep-06-23 07:00AM
Aug-31-23 10:12PM
Aug-16-23 02:54PM
Aug-09-23 05:40PM
04:05PM
Aug-05-23 03:30PM
Jul-16-23 10:36AM
Jun-08-23 09:49AM
07:00AM
Jun-07-23 04:05PM
Jun-06-23 07:00AM
Jun-05-23 06:36AM
Jun-02-23 07:00AM
May-22-23 07:00AM
May-14-23 08:04AM
May-12-23 06:19AM
May-11-23 06:13AM
May-09-23 06:55PM
04:05PM
May-03-23 09:55AM
Apr-28-23 04:05PM
Apr-18-23 02:32PM
10:15AM
Mar-29-23 07:25AM
Mar-14-23 04:58PM
Mar-02-23 05:39AM
Feb-28-23 08:15PM
04:05PM
Feb-06-23 05:18AM
Feb-02-23 07:00AM
Jan-24-23 04:33AM
Jan-20-23 09:55AM
Jan-19-23 07:00AM
Dec-27-22 05:34AM
Dec-19-22 07:00AM
Dec-02-22 10:54AM
09:35AM
Dec-01-22 09:55AM
Nov-16-22 05:35AM
Nov-14-22 09:55AM
Nov-09-22 05:35PM
04:05PM
Nov-07-22 07:00AM
Oct-13-22 11:08AM
Oct-12-22 09:10AM
Repare Therapeutics, Inc. engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company was founded on September 6, 2016 and is headquartered in Saint-Laurent, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Segal Lloyd MitchellPRESIDENT AND CEOMar 28 '24Sale4.622,65012,243110,049Apr 01 09:31 PM
Segal Lloyd MitchellPRESIDENT AND CEOApr 01 '24Sale4.632,49111,533107,558Apr 01 09:31 PM
Forte SteveEVP, CHIEF FINANCIAL OFFICERMar 28 '24Sale4.628253,81245,564Apr 01 09:30 PM
Forte SteveEVP, CHIEF FINANCIAL OFFICERApr 01 '24Sale4.617893,63744,775Apr 01 09:30 PM
Zinda MichaelEVP, CHIEF SCIENTIFIC OFFICERMar 28 '24Sale4.644502,08872,318Apr 01 09:28 PM
Zinda MichaelEVP, CHIEF SCIENTIFIC OFFICERApr 01 '24Sale4.664101,91171,908Apr 01 09:28 PM
Koehler MariaEVP, CHIEF MEDICAL OFFICERMar 28 '24Sale4.645002,320231,709Apr 01 09:27 PM
Koehler MariaEVP, CHIEF MEDICAL OFFICERApr 01 '24Sale4.663001,398231,409Apr 01 09:27 PM
Forte SteveEVP, CHIEF FINANCIAL OFFICERMar 25 '24Sale4.798253,95243,862Mar 27 06:59 PM
Forte SteveEVP, CHIEF FINANCIAL OFFICERMar 27 '24Sale4.628253,81242,212Mar 27 06:59 PM
Forte SteveEVP, CHIEF FINANCIAL OFFICERMar 26 '24Sale4.608253,79543,037Mar 27 06:59 PM
Zinda MichaelEVP, CHIEF SCIENTIFIC OFFICERMar 25 '24Sale4.784502,15173,668Mar 27 06:57 PM
Zinda MichaelEVP, CHIEF SCIENTIFIC OFFICERMar 27 '24Sale4.624502,07972,768Mar 27 06:57 PM
Zinda MichaelEVP, CHIEF SCIENTIFIC OFFICERMar 26 '24Sale4.614502,07473,218Mar 27 06:57 PM
Koehler MariaEVP, CHIEF MEDICAL OFFICERMar 25 '24Sale4.785002,390233,209Mar 27 06:56 PM
Koehler MariaEVP, CHIEF MEDICAL OFFICERMar 27 '24Sale4.625002,310232,209Mar 27 06:56 PM
Koehler MariaEVP, CHIEF MEDICAL OFFICERMar 26 '24Sale4.605002,300232,709Mar 27 06:56 PM
Segal Lloyd MitchellPRESIDENT AND CEOMar 25 '24Sale4.792,65012,69489,166Mar 27 06:54 PM
Segal Lloyd MitchellPRESIDENT AND CEOMar 26 '24Sale4.642,65012,29686,516Mar 27 06:54 PM
Segal Lloyd MitchellPRESIDENT AND CEOMar 27 '24Sale4.632,65012,27083,866Mar 27 06:54 PM
Koehler MariaEVP, Chief Medical OfficerDec 11 '23Option Exercise2.2643,74698,755219,709Dec 12 04:19 PM